What is more, the availability of a large number of P2X7 antagonists makes the receptor a particularly attractive target for new therapies; thus, its role in glioma biology is undoubtedly worth further investigation [17, 26–30]. The gene discussed is P2RX7; the disease is central nervous system cancer.